L. Farbman

551 citations
12 papers · 417 indexed · h-index 10
Topics
Neutropenia and Cancer Infections (4 papers)Bacterial Identification and Susceptibility Testing (3 papers)Hematological disorders and diagnostics (3 papers)
Partner nations
Israel

In The Last Decade

L. Farbman

12 papers receiving 403 citations

Peers

L. Farbman
Comparison fields: 5 of 77
  • Molecular Medicine 177
  • Epidemiology 133
  • Pharmacology 113
  • Oncology 81
  • Infectious Diseases 63
Replace Tiffany E. Bias with:
Tiffany E. Bias United States
Nadim G. El Chakhtoura United States
Katherine A. Sulham United States
Jaime Lora‐Tamayo Spain
Dania Abdallah Lebanon
Patra Koletsi Greece
Yuarn‐Jang Lee Taiwan
Pavithra Srinivas United States
Naoya Nishiyama Japan
David Aguilera‐Alonso Spain
L. Farbman relative to Tiffany E. Bias United States Tiffany E. Bias's profile →
Citations per field
00.5×10×16.2×
Tiffany E. Bias · 1×
Citations per year

Countries citing papers authored by L. Farbman

Since Specialization
Citations

This map shows the geographic impact of L. Farbman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Farbman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Farbman more than expected).

Fields of papers citing papers by L. Farbman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Farbman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Farbman. The network helps show where L. Farbman may publish in the future.

Co-authorship network of co-authors of L. Farbman

This figure shows the co-authorship network connecting the top 25 collaborators of L. Farbman. A scholar is included among the top collaborators of L. Farbman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Farbman. L. Farbman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 13
2 29
3 4
4 7
5 31
6 23
7 30
8 10
9 15
10 35
11 20
12 200

About L. Farbman

L. Farbman is a scholar working on Clinical Biochemistry, Molecular Medicine and Emergency Medicine, having authored 12 papers that have together received 417 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Hematological disorders and diagnostics (3 papers). The work is most often cited by research in Molecular Medicine (177 citations), Applied Microbiology and Biotechnology (51 citations) and Pharmacology (113 citations). L. Farbman has collaborated with scholars based in Israel. Frequent co-authors include Mical Paul, Leonard Leibovici, Dafna Yahav, Anat Gafter‐Gvili, Adi Lador, Noa Eliakim‐Raz, Salomon M. Stemmer, Vered Daitch, Tomer Avni and Bina Rubinovitch. Their work appears in journals such as Cancer, Clinical Microbiology and Infection and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026